sermonixpharma.com

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: /wp-admin/admin-ajax.php Disallow: /wp-admin/ Sitemap: https://sermonixpharma.com/sitemap.xml Sitemap:

Meta Tags

Title	Sermonix
Description	Passion & Purpose in Women’s Ohio-based biopharmaceutical company with a precision medicine focus for bringing targeted oncology products through development, approval, and
Keywords	N/A

Server Information

WebSite	sermonixpharma.com
Host IP	104.207.140.92
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

sermonixpharma.com Valuation

US$5,286,332

Last updated: 2023-05-10 05:21:14

sermonixpharma.com has Semrush global rank of 2,002,202. sermonixpharma.com has an estimated worth of US$ 5,286,332, based on its estimated Ads revenue. sermonixpharma.com receives approximately 609,962 unique visitors each day. Its web server is located in United States, with IP address 104.207.140.92. According to SiteAdvisor, sermonixpharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$5,286,332
Daily Ads Revenue	US$4,880
Monthly Ads Revenue	US$146,391
Yearly Ads Revenue	US$1,756,689
Daily Unique Visitors	40,665
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
sermonixpharma.com.	A	7199	IP: 104.207.140.92
sermonixpharma.com.	NS	3600	NS Record: ns13.domaincontrol.com.
sermonixpharma.com.	NS	3600	NS Record: ns14.domaincontrol.com.
sermonixpharma.com.	MX	13113	MX Record: 10 sermonixpharma-com.mail.protection.outlook.com.
sermonixpharma.com.	TXT	21599	TXT Record: MS=ms35582746
sermonixpharma.com.	TXT	21599	TXT Record: v=spf1 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-05-10 05:21:14

614-864-4919 info@sermonixpharma.com Facebook Twitter Google --> Linkedin RSS Facebook Twitter Google --> Linkedin RSS About Company Overview Management Team Board of Directors Oncology Steering Committee Partners & Collaborations Breast Cancer Pipeline Lasofoxifene For Patients The ELAINE Study The ELAINE 2 Study News & Media News Media Medical Meetings Contact Select Page Passion & Purpose in Women’s Oncology Learn more Clinical news on the horizon View the latest trial data Passion & Purpose in Women’s Oncology Company Overview Founded in late 2014 by David Portman, MD, a leading clinical researcher and expert in women’s health, Sermonix Pharmaceuticals is a privately held biotechnology company focused on the development and commercialization of female-specific oncology products. The ELAINE Study The ELAINE Study is an open-label, randomized, multicenter study evaluating the activity of lasofoxifene relative to fulvestrant for the treatment of postmenopausal women and

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx-rc
Date: Tue, 02 Nov 2021 05:24:21 GMT
Content-Type: text/html
Content-Length: 174
Connection: keep-alive
Location: https://sermonixpharma.com/

HTTP/2 200 
server: nginx-rc
date: Tue, 02 Nov 2021 05:24:22 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
set-cookie: apbct_timestamp=1635830661; path=/; HttpOnly; SameSite=Lax
set-cookie: apbct_site_landing_ts=1635830661; path=/; HttpOnly; SameSite=Lax
set-cookie: apbct_page_hits=1; path=/; HttpOnly; SameSite=Lax
set-cookie: apbct_cookies_test=%257B%2522cookies_names%2522%253A%255B%2522apbct_timestamp%2522%252C%2522apbct_site_landing_ts%2522%252C%2522apbct_page_hits%2522%255D%252C%2522check_value%2522%253A%2522ce3d183fb2f2db6a2e992c3028b42951%2522%257D; path=/; HttpOnly; SameSite=Lax
set-cookie: PHPSESSID=nbulmn4g7qc8fjais57o72nhcc; path=/
expires: Thu, 19 Nov 1981 08:52:00 GMT
cache-control: no-store, no-cache, must-revalidate
pragma: no-cache
link: ; rel="https://api.w.org/"
link: ; rel=shortlink
strict-transport-security: max-age=15768000
x-frame-options: SAMEORIGIN
x-xss-protection: 1; mode=block
x-content-type-options: nosniff

sermonixpharma.com Whois Information

Domain Name: SERMONIXPHARMA.COM
Registry Domain ID: 1893016701_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2019-09-25T17:14:18Z
Creation Date: 2014-12-29T14:23:23Z
Registry Expiry Date: 2022-12-29T14:23:23Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS13.DOMAINCONTROL.COM
Name Server: NS14.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-20T13:41:06Z <<<

sermonixpharma.com valuation and analysis